XOMA Initiates Phase I U.S. Trial in Type 2 Diabetes for XOMA 052, Monoclonal Antibody With Therapeutic Potential in Multiple Inflammatory Diseases Jul 16, 2007 8:35am EDT
XOMA Executives to Present at BIO2007 Convention, Rodman & Renshaw Global Healthcare, Needham Biotechnology and Jefferies Healthcare Conferences May 07, 2007 6:30pm EDT
XOMA Announces May 10 Conference Call and Webcast Discussion of First Quarter 2007 Financial Results Apr 26, 2007 7:01pm EDT
XOMA Announces Automatic Conversion of All Remaining Outstanding Convertible Notes Mar 07, 2007 9:05am EST
XOMA Announces March 8 Conference Call and Webcast Discussion of Fourth Quarter and Full-Year 2006 Results Mar 02, 2007 2:00pm EST
XOMA and Takeda Expand Collaboration for Therapeutic Antibody Discovery and Development Feb 28, 2007 3:07am EST
